Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Knowing what to say when negotiating debt is crucial for success. Use these tips to communicate effectively and secure favorable repayment terms.
18,740 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
U.S. equities drift as tariff uncertainty lingers, with the S&P 500 and SPY easing while investors await policy clari...
A Mesa resident with an $800,000 nest egg and about $2,700 monthly Social Security weighs whether desert living fits ...
C2 Financial announced a nationwide expansion to reclaim its No. 1 wholesale ranking. The plan centers on AI upgrades...
A bigger 2027 COLA might sound like good news, but two hidden costs could catch retirees off guard. This guide breaks...
Home Depot’s stock surge followed a better-than-expected quarterly showing, with comps rising and margins improving. ...
A dividend-focused ETF beats a broad market gain on yield and stability. Invesco’s SPHD offers 4.57% income with lowe...
Retirees are discovering a niche income strategy that delivers roughly 5% yields with minimal price swings. This arti...
Palantir has won a landmark Army data overhaul deal worth $10 billion, signaling a decade-long shift in defense IT an...
Gen Z is pushing a rebound in vinyl records and print media, shaping the market while stretching household budgets. T...
Bitcoin’s price dip below $60,000 tests investor confidence as Strategy unveils a $2.55 billion reserve plan and a du...
A wave of selling hit AI-related shares after a blog post framed AI gains as 'science fiction.' Behavioral finance ex...